Holen Sie sich die Stockscreener-App
1.20
4.35%
0.05
Handel nachbörslich:
1.20
Schlusskurs vom Vortag:
$1.15
Offen:
$1.13
24-Stunden-Volumen:
339.75K
Relative Volume:
0.50
Marktkapitalisierung:
$44.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-25.94M
KGV:
-0.8696
EPS:
-1.38
Netto-Cashflow:
$-15.79M
1W Leistung:
-26.83%
1M Leistung:
+18.81%
6M Leistung:
-33.33%
1J Leistung:
-38.14%
1-Tages-Spanne:
$1.13
$1.26
1-Wochen-Bereich:
$1.13
$1.75
52-Wochen-Spanne:
$0.87
$2.74
MAIA Biotechnology Inc Stock (MAIA) Company Profile
Firmenname
MAIA Biotechnology Inc
Sektor
Branche
Telefon
312 416 8592
Adresse
444 West Lake Street, Suite 1700, Chicago
Vergleichen Sie MAIA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MAIA
MAIA Biotechnology Inc
|
1.20 | 42.59M | 0 | -25.94M | -15.79M | -1.38 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten
How MAIA Biotechnology Inc. stock compares to industry benchmarksTrade Ideas & Low Risk Entry Point Tips - Улправда
MAIA Biotechnology announces $2.25M private placement deal - MSN
MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks
MAIA Biotechnology (NYSE American: MAIA) details $2.25M private placement - Stock Titan
MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times
MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com
MAIA Biotechnology Announces Significant Insider Buying - TipRanks
MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets
MAIA Biotechnology (NYSE: MAIA) starts Ateganosine Phase 3 trial and notes insider buying - Stock Titan
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates - Yahoo Finance
MAIA Biotechnology (MAIA) doses first patient in THIO-104 Phase 3 NSCLC trial - Stock Titan
MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - Yahoo Finance
MAIA Biotechnology announces significant insider buying - MSN
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks
MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets
MAIA Biotechnology (NYSE: MAIA) highlights $50B immunotherapy market in press release - Stock Titan
MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times
Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com
MAIA Biotechnology (NYSE American: MAIA) starts Phase 3 telomere drug trial in NSCLC - Stock Titan
Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks
Dir Smith Buys 13,740 ($16.4K) Of Maia Biotechnology Inc [MAIA] - TradingView — Track All Markets
Can MAIA Biotechnology Inc. stock sustain revenue momentum2025 Price Targets & Real-Time Price Movement Reports - Newser
How MAIA Biotechnology Inc. stock reacts to bond yieldsWeekly Gains Summary & Free Technical Pattern Based Buy Signals - Newser
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock By Investing.com - Investing.com Australia
Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock - Investing.com
Is MAIA Biotechnology Inc. stock among top earnings plays2025 Stock Rankings & Daily Chart Pattern Signals - Newser
How MAIA Biotechnology Inc. stock compares with top peersMarket Trend Summary & Fast Gain Swing Alerts - Newser
Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares - Investing.com Canada
Why hedge funds are buying MAIA Biotechnology Inc. stockRisk Management & Daily Risk Controlled Trade Plans - Newser
MAIA Biotechnology Inc (MAIA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - setenews.com
How MAIA Biotechnology Inc. stock responds to policy changesTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Will MAIA Biotechnology Inc. stock return to pre crash levels2025 Bull vs Bear & Smart Allocation Stock Reports - Newser
How MAIA Biotechnology Inc. stock compares with market leaders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Will MAIA Biotechnology Inc. stock recover faster than industryAnalyst Upgrade & Safe Entry Zone Tips - Newser
Why MAIA Biotechnology Inc. stock could rally stronglyJuly 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Top Executives Make Bold Moves with Major Stock Purchases at MAIA Biotechnology! - TipRanks
MAIA SEC FilingsMAIA Biotechnology Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Maia Biotechnology announces open market purchases by CEO and directors - marketscreener.com
MAIA Biotechnology Announces Open Market Purchases by CEO and Directors - The Manila Times
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 By Investing.com - Investing.com Australia
Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares By Investing.com - Investing.com South Africa
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares By Investing.com - Investing.com South Africa
Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848 - Investing.com India
Smith Stan, MAIA Biotechnology director, buys $15,582 in shares - Investing.com
Finanzdaten der MAIA Biotechnology Inc-Aktie (MAIA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
Kapitalisierung:
|
Volumen (24h):